Lifirafenib

Scientific Overview: Pan-RAF inhibitor with EGFR inhibition; active in RAS-mutant cancers; combined with MEK inhibitor. Pan-RAF coverage including CRAF — RAS-mutant activity

Mechanism of Action: Pan-RAF + EGFR Inhibitor

Purity: ≥99%  |  Molecular Formula: C25H27F3N4O4S

For Research Use Only. Not intended for diagnostic, therapeutic, or clinical applications.